• Skip to content
  • Skip to primary sidebar

Davis+Gilbert LLP

From our base in New York, we represent a diverse range of clients across the country and around the world.

  • People
  • Services
  • Emerging Issues

Advertising + Marketing Alert

CCPA Update: Blizzard of Bills to Amend Privacy Law Moves Forward in California Assembly

April 26, 2019 by Megan O'Malley

The Bottom Line The marketing industry has been pleading for amendments to the CCPA and some helpful amendments have now been advanced. Should these amendments become law, they could offer some relief to the industry.Regardless, the industry is still awaiting the California Attorney General to Continue Reading

Alert - April 26, 2019

FTC Plans Workshop on ‘Loot Boxes’

April 11, 2019 by Megan O'Malley

The Bottom Line A strong push has come forth from the likes of Senator Hassan, other legislators, the FTC and consumer lawsuits regarding consumer protection issues related to “loot boxes” in video games. This year may see efforts at regulating loot boxes move forward to the extent they have not Continue Reading

Alert - April 11, 2019

Video Social Networking App Agrees to Pay $5.7 Million to Settle FTC’s COPPA Action

March 25, 2019 by Megan O'Malley

The Bottom Line The sheer size of the Musical.ly settlement illustrates that the FTC continues to have a strong interest in enforcing COPPA. Online services cannot hide behind language in their terms and conditions claiming not to be child-directed when they include numerous activities that Continue Reading

Alert - March 25, 2019

FTC Brings First Action Against Company for Posting Fake Reviews

March 12, 2019 by Megan O'Malley

The Bottom Line It should come as no surprise to companies that they should not be purchasing or posting fake reviews of their products as a way to improve sales to customers. The action against Cure Encapsulations and its owner shows that the FTC is interested in taking action to halt the Continue Reading

Alert - March 12, 2019

FTC and FDA Sent Warning Letters to Companies Advertising Products that Claim Treatment of Disease

March 7, 2019 by Megan O'Malley

The Bottom Line The FTC and FDA are aggressively reviewing companies’ websites and social media channels for false or unsubstantiated health claims and efficacy claims. Advertisements on company websites and in social media posts must avoid false or unsubstantiated health claims, and efficacy Continue Reading

Alert - March 7, 2019

As More States Legalize Marijuana, Advertising and Marketing Regulations Come Into Focus

February 14, 2019 by Megan O'Malley

The Bottom Line The advertising opportunities in this evolving industry are hard to ignore. However, with more opportunities comes more confusion, as state advertising regulations differ and the conflicts with the federal government become increasingly complicated. All participants in the Continue Reading

Alert - February 14, 2019

New York and Florida AGs Settle Charges with Seller of Fake Social Media Accounts and Engagements

February 13, 2019 by Megan O'Malley

The Bottom Line Brands, marketers, and their agencies typically have the most to lose due to fraudulent social media traffic, in the form of wasted marketing dollars spent appealing to non-existent users. However, these settlements made clear that such practices also harm consumers and social Continue Reading

Alert - February 13, 2019

Mastercard Announces New Free Trial Rules for Merchants

February 6, 2019 by Megan O'Malley

The Bottom Line Companies that engage in negative option and subscription-based marketing must comply with various federal and state laws governing their practices. The proposed Mastercard rules will add another set of requirements to this compliance landscape. Marketers should prepare to comply Continue Reading

Alert - February 6, 2019

The FTC’s “Reasonable Basis” Standard Has Evolved for Disease Efficacy Claims

January 9, 2019 by Megan O'Malley

The Bottom Line The FTC made it clear many times in 2018 that disease efficacy claims must be supported by competent and reliable scientific evidence, including human clinical testing, and that expert opinions will help guide the kind of human clinical testing and the number of RCTs that is Continue Reading

Alert - January 9, 2019

Celebrity Endorsers of Initial Coin Offerings Settle with Securities and Exchange Commission

December 20, 2018 by Patrick Quinn

The Bottom Line Celebrities not only need to comply with the FTC Endorsement Guides but also need to comply with the SEC’s disclosure rules when endorsing ICOs, or risk facing charges similar to those brought against Khaled and Mayweather.These recent charges reflect the SEC’s concern around the Continue Reading

Alert - December 20, 2018

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Go to Next Page »

Primary Sidebar

  • Sitemap
  • Privacy Policy
  • Terms and Conditions
  • Accessibility Statement
  • About Us
  • Location
  • Subscribe
© 2025 Copyright Davis+Gilbert LLP. Attorney Advertising.
  • People
  • Services
  • Emerging Issues
  • Insights + Events
  • Culture + Community
  • Pro Bono + Corporate Social Responsibility
  • Careers
  • About Us
  • Subscribe
  • Location
This site uses cookies to store information on your device. These cookies either support essential functions of the site or are used to develop analytics regarding usage of our site. Click Accept to continue using the site with our recommended settings or click Decline to disable non-essential cookies.AcceptDecline